SPSIPB vs. SAPB in Breast Surgery
Serratus Posterior Superior Intercostal Plane Block Versus Serratus Anterior Plane Block for Breast Surgery: A Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
The effects of the newly defined serratus posterior superior intercostal plane block and serratus anterior plane block on postoperative analgesia and quality of recovery in women undergoing breast surgery will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Apr 2025
Shorter than P25 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 15, 2025
CompletedFirst Posted
Study publicly available on registry
April 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedApril 29, 2025
April 1, 2025
5 months
April 15, 2025
April 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative opioid consumption
total opioid consumption during postoperative 24 hours
up to 24 hour after surgery
Secondary Outcomes (2)
Postoperative pain scores
postoperative 2nd 6th, 12th 24th hour
quality of recovery
postoperative 24 hour
Study Arms (3)
Group Control
NO INTERVENTIONGroup SPSIPB
ACTIVE COMPARATORGroup SAPB
ACTIVE COMPARATORInterventions
administer 30 mL %0.25 bupivacain between third costa and serratus posterior superior muscle
administer 30 mL %0.25 bupivacain between 5th costa and serratus anterior muscle in midaxiller line
Eligibility Criteria
You may qualify if:
- Patients who have received informed consent form Patients who will undergo Breast Cancer Surgery aged between 18-65
You may not qualify if:
- \<18 years and \>65 years
- ASA ≥ IV
- History of allergy to local anesthetics
- Clinical diagnosis of coagulation disorders
- Infection near the entry site
- Chronic analgesic use Patients who will undergo bilateral Breast Cancer Surgery
- Body mass index \>35
- Clinical diagnosis of Dementia or confusion
- Lack of cooperation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zonguldak Bülent Ecevit University Medicine Faculty
Zonguldak, Kozlu, 67600, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 15, 2025
First Posted
April 29, 2025
Study Start
April 1, 2025
Primary Completion
August 30, 2025
Study Completion
October 1, 2025
Last Updated
April 29, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share